Watermark
  Back to Search Results

BGB-900-105

Completed

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-900-105

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04047862

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20202608

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan